Form 8-K - Current report:
SEC Accession No. 0001193125-25-135942
Filing Date
2025-06-05
Accepted
2025-06-05 16:52:32
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d90930d8k.htm   iXBRL 8-K 52446
  Complete submission text file 0001193125-25-135942.txt   163994

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20250605.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20250605_lab.xml EX-101.LAB 17167
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20250605_pre.xml EX-101.PRE 10806
15 EXTRACTED XBRL INSTANCE DOCUMENT d90930d8k_htm.xml XML 3614
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 251027841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)